Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Completed

Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin

NCT04387461

Conditions
Carcinoma, Carcinoma in Situ, Female Urogenital Diseases, +14 more
Locations
  • University of California - San Diego La Jolla, California, United States
  • University of California - Irvine Orange, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Northwestern University Tampa, Florida, United States
View all 19 locations
View Trial Details
Completed

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT05136898

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations
  • Urology Centers of Alabama (UCA) Homewood, Alabama, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Medication Management Greensboro, North Carolina, United States
  • Urology Associates, P.C. Nashville, Tennessee, United States
View Trial Details
Completed

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

NCT02773849

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Keck School of Medicine at USC Medical Center Los Angeles, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
  • University of Florida - UF Health Davis Center Pavilion and Shands Med Plaza Gainesville, Florida, United States
View all 34 locations
View Trial Details
Completed

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

NCT03636256

Conditions
Bladder Cancer, Cancer of the Bladder, Carcinoma, +20 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • James Buchanan Brady Urological Institute, Johns Hopkins Medical Institutions Baltimore, Maryland, United States
  • Columbia University Herbert Irving Comprehensive Cancer Center New York, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details

Related conditions